翰宇药业 (300199.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(翰宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 375,225,390.50255,720,574.14150,256,744.79431,384,112.87401,555,248.48325,278,801.43176,222,802.86
 营业收入(元) 375,225,390.50255,720,574.14150,256,744.79431,384,112.87401,555,248.48325,278,801.43176,222,802.86
二、营业总成本(元) 459,578,775.38309,314,966.43156,147,173.76888,444,319.54635,023,336.89428,738,428.05201,091,127.75
 营业成本(元) 151,708,440.89102,068,191.2459,400,451.09218,686,716.09146,684,554.8893,418,150.2049,589,539.90
 研发费用(元) 59,329,000.1540,911,586.3718,999,351.04161,495,617.93118,110,953.6387,802,058.2344,393,211.43
 营业税金及附加(元) 6,045,567.474,537,164.551,447,681.3612,656,249.327,849,806.556,494,405.322,138,543.25
 销售费用(元) 70,260,228.9043,338,190.8316,088,786.79242,641,567.93164,916,269.68111,207,682.8540,763,914.17
 管理费用(元) 85,209,042.2360,577,268.4929,821,195.75127,699,778.62105,750,385.2971,973,449.4135,413,183.95
 财务费用(元) 87,026,495.7457,882,564.9530,389,707.73125,264,389.6591,711,366.8657,842,682.0428,792,735.05
  其中:利息费用(元) 79,425,721.2753,147,900.5026,164,132.23120,461,172.4587,730,992.3855,524,371.2927,907,368.98
  其中:利息收入(元) 191,207.56131,998.21102,893.91216,652.69172,725.28109,498.3659,437.78
三、其他经营收益
 加:公允价值变动收益(元) ---44,491,998.0654,026,991.4062,695,801.8027,781,417.40
 加:投资收益(元) -529,557.23-181,717.39--9,785,663.14-12,928,783.98-12,257,669.44-263,908.12
  其中:对联营企业和合营企业的投资收益(元) -529,557.23-181,717.39-3,195,102.5647,008.1547,008.15-
 资产处置收益(元) 42,676,324.1443,009,866.40664,407.59-512,286.49106,293.4963,000.4063,000.40
 资产减值损失(元) 3,465,987.555,040,472.1362,258.13-126,095,488.6912,114,959.906,855,843.76-
 信用减值损失(元) -5,424,779.04-4,779,460.42-3,388,149.62-8,854,452.69-11,679,875.27-8,330,894.56-1,766,646.00
 其他收益(元) 17,937,162.777,789,038.813,637,297.0750,311,442.1828,746,770.9023,757,181.7019,243,596.09
四、营业利润(元) -26,228,246.69-2,716,192.76-4,914,615.80-507,504,657.44-163,081,731.97-30,676,362.9620,189,134.88
 加:营业外收入(元) 98,331.8020,685.25858.03260,946.90131,158.4068,552.9338,370.31
 减:营业外支出(元) 1,464,030.721,121,853.074,685,646.273,859,611.2113,905,715.641,591,439.933,305,199.49
五、利润总额(元) -27,593,945.61-3,817,360.58-9,599,404.04-511,103,321.75-176,856,289.21-32,199,249.9616,922,305.70
 减:所得税费用(元) 8,234,810.627,154,029.214,750,646.984,339,473.434,918,689.752,758,766.15-1,343,030.77
六、净利润(元) -35,828,756.23-10,971,389.79-14,350,051.02-515,442,795.18-181,774,978.96-34,958,016.1118,265,336.47
(一)按经营持续性分类
  持续经营净利润(元) -35,828,756.23-10,971,389.79-14,350,051.02-515,442,795.18-181,774,978.96-34,958,016.1118,265,336.47
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -34,805,639.91-10,358,793.27-14,102,003.37-513,876,149.69-180,549,363.99-34,133,703.8818,605,574.69
  少数股东损益(元) -1,023,116.32-612,596.52-248,047.65-1,566,645.49-1,225,614.97-824,312.23-340,238.22
 扣除非经常性损益后的净利润(元) -93,577,678.87-59,723,767.45-16,074,914.16-590,913,670.38-236,070,560.85-106,372,963.05-24,692,107.75
七、每股收益
 一、基本每股收益(元) -0.04-0.01-0.02-0.58-0.20-0.040.02
 二、稀释每股收益(元) -0.04-0.01-0.02-0.58-0.20-0.040.02
八、其他综合收益(元) -713,914.14644,068.57238,209.621,771,775.423,177,814.193,747,769.27-1,230,539.09
 归属于母公司股东的其他综合收益(元) -713,914.14644,068.57238,209.621,771,775.423,177,814.193,747,769.27-1,230,539.09
九、综合收益总额(元) -36,542,670.37-10,327,321.22-14,111,841.40-513,671,019.76-178,597,164.77-31,210,246.8417,034,797.38
 归属于母公司所有者的综合收益总额(元) -35,519,554.05-9,714,724.70-13,863,793.75-512,104,374.27-177,371,549.80-30,385,934.6117,375,035.60
 归属于少数股东的综合收益总额(元) -1,023,116.32-612,596.52-248,047.65-1,566,645.49-1,225,614.97-824,312.23-340,238.22
公告日期 2024-10-302024-08-242024-04-272024-04-272023-10-302023-08-152023-04-27
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院